Cancer biomarkers
- PMID: 22356776
- PMCID: PMC5528374
- DOI: 10.1016/j.molonc.2012.01.010
Cancer biomarkers
Abstract
Biomarkers have many potential applications in oncology, including risk assessment, screening, differential diagnosis, determination of prognosis, prediction of response to treatment, and monitoring of progression of disease. Because of the critical role that biomarkers play at all stages of disease, it is important that they undergo rigorous evaluation, including analytical validation, clinical validation, and assessment of clinical utility, prior to incorporation into routine clinical care. In this review we address key steps in the development of biomarkers, including ways to avoid introducing bias and guidelines to follow when reporting results of biomarker studies.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Similar articles
-
State of the art and trends of circulating cancer biomarkers.Int J Biol Markers. 2020 Feb;35(1_suppl):12-15. doi: 10.1177/1724600819900512. Int J Biol Markers. 2020. PMID: 32079467
-
Biomarkers: a framework driving advances in oncology.Biomark Med. 2015;9(4):303-6. doi: 10.2217/bmm.15.7. Biomark Med. 2015. PMID: 25808434 No abstract available.
-
Biomarker validation and testing.Mol Oncol. 2015 May;9(5):960-6. doi: 10.1016/j.molonc.2014.10.004. Epub 2014 Oct 18. Mol Oncol. 2015. PMID: 25458054 Free PMC article. Review.
-
The pathway to clinical use of a cancer biomarker.Scand J Clin Lab Invest Suppl. 2016;245:S17-21. doi: 10.1080/00365513.2016.1206441. Epub 2016 Jul 13. Scand J Clin Lab Invest Suppl. 2016. PMID: 27410238 Review.
-
Validation of new cancer biomarkers: a position statement from the European group on tumor markers.Clin Chem. 2015 Jun;61(6):809-20. doi: 10.1373/clinchem.2015.239863. Epub 2015 Apr 16. Clin Chem. 2015. PMID: 25882892 Review.
Cited by
-
Recent advances in minimally invasive biomarkers of OSCC: from generalized to personalized approach.Front Oral Health. 2024 Aug 2;5:1426507. doi: 10.3389/froh.2024.1426507. eCollection 2024. Front Oral Health. 2024. PMID: 39157206 Free PMC article. Review.
-
Evaluation of Mir-1290 as a Possible Diagnostic Factor in the Serum of Oral Squamous Cell Carcinoma Patients with Qualitative Real-Time Polymerase Chain Reaction.Iran J Pathol. 2024 Spring;19(2):244-249. doi: 10.30699/IJP.2024.2010130.3161. Epub 2024 Feb 15. Iran J Pathol. 2024. PMID: 39118790 Free PMC article.
-
Potential of sonobiopsy as a novel diagnosis tool for brain cancer.Mol Ther Oncol. 2024 Jun 24;32(3):200840. doi: 10.1016/j.omton.2024.200840. eCollection 2024 Sep 19. Mol Ther Oncol. 2024. PMID: 39077551 Free PMC article. Review.
-
Morphological and Immunocytochemical Characterization of Paclitaxel-Induced Microcells in Sk-Mel-28 Melanoma Cells.Biomedicines. 2024 Jul 16;12(7):1576. doi: 10.3390/biomedicines12071576. Biomedicines. 2024. PMID: 39062149 Free PMC article.
-
Biosensors for Cancer Biomarkers Based on Mesoporous Silica Nanoparticles.Biosensors (Basel). 2024 Jun 30;14(7):326. doi: 10.3390/bios14070326. Biosensors (Basel). 2024. PMID: 39056602 Free PMC article. Review.
References
-
- Allegra, C.J. , Jessup, J.M. , Somerfield, M.R. , Hamilton, S.R. , Hammond, E.H. , Hayes, D.F. , McAllister, P.K. , Morton, R.F. , Schilsky, R.L. , 2009. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J. Clin. Oncol.. 27, 2091–2096. - PubMed
-
- Allred, D.C. , 2008. Commentary: hormone receptor testing in breast cancer: a distress signal from Canada. Oncologist. 13, 1134–1136. - PubMed
-
- Baggerly, K.A. , Morris, J.S. , Coombes, K.R. , 2004. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics. 20, 777–785. - PubMed
-
- Bang, Y.J. , Van Cutsem, E. , Feyereislova, A. , Chung, H.C. , Shen, L. , Sawaki, A. , Lordick, F. , Ohtsu, A. , Omuro, Y. , Satoh, T. , Aprile, G. , Kulikov, E. , Hill, J. , Lehle, M. , Ruschoff, J. , Kang, Y.K. , 2010. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 376, 687–697. - PubMed
-
- Bossuyt, P.M. , Reitsma, J.B. , Bruns, D.E. , Gatsonis, C.A. , Glasziou, P.P. , Irwig, L.M. , Moher, D. , Rennie, D. , de Vet, H.C. , Lijmer, J.G. , 2003. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann. Intern. Med.. 138, W1–12. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources